Innovative PFA Alternatives That Unlock Health Capital in 2026
Health systems entered 2026 with a familiar problem: demand for convenient outpatient care keeps rising, but capital is still “good—not cheap.” Rates have eased at the margins, lenders remain selective, and boards are scrutinizing every dollar of debt capacity. At the same time, operating performance is uneven across the industry, creating a widening gap between systems that can move and systems that must wait.
That’s why more CFOs and real estate leaders are revisiting Public Finance Authority (PFA) financing—and just as importantly, asking what comes next when PFA isn’t the right tool for the job. In this guide, we’ll clarify what PFA financing actually is, why it’s attractive, and the most practical alternatives we’re seeing health systems use in 2026 to unlock growth while protecting financial resilience.
First: What PFA Financing Is (and Isn’t)
PFA is a conduit issuer that helps eligible public and private entities access tax-exempt (and taxable) bond financing. In plain terms, PFA can serve as the issuing authority for a borrowing structure that may lower the all-in cost of capital when the project and borrower qualify. For many nonprofit health systems and affiliated organizations, that can be a compelling way to finance facility projects, equipment, or refinance existing debt—when timing, structure, and eligibility align.
But PFA financing is not a “pool of money,” and it’s not always fast. Conduit bond financing can involve documentation, approvals, and coordination across advisors. In 2026, speed-to-market matters—especially for ambulatory strategies—so many leaders are pairing tax-exempt tools with more flexible capital structures that can execute faster and preserve balance sheet capacity.
Why the Question Is Louder in 2026
Three macro forces are pushing capital strategy back to the top of the agenda:
- Margins are improving for some, but expenses and regional performance remain volatile—making “one-size-fits-all” capital decisions risky.
- Rates and credit are more supportive than 2024–2025, but the market is still selective; clean structures and strong credit win.
- Outpatient growth is pulling the train. Projects that can open sooner—on the right sites with repeatable prototypes—capture volume while competitors wait.
In other words: 2026 rewards execution. The best financing approach is the one that matches your speed, risk tolerance, governance, and long-term operating plan.
The Best Alternatives to PFA Financing for Health Systems
1) Developer Capital + Programmatic Delivery
For ambulatory networks, the fastest path to growth often isn’t “more debt”—it’s a repeatable delivery model with flexible capital. Developer capital can fund parts of a project that would otherwise consume your debt capacity, while still preserving strategic control over location, design standards, and long-term operating performance.
Where Boldt Real Estate fits:
- Programmatic outpatient delivery: standardize what repeats (clinic prototypes, specs, procurement) to reduce cycle time and change orders.
- Flexible financing structures: align capital to strategy—whether you need to preserve debt capacity, share risk, or keep an ownership pathway open.
- Real estate as a growth platform: treat sites and facilities as an extension of access strategy, not just a capital project.
If you’re trying to open clinics faster in 2026, let’s map a programmatic pipeline—sites, prototypes, schedule, and capital—so your first opening funds the next.
2) Joint Ventures That Preserve Capital and Build Equity
JV structures have become a go-to option when systems want control and long-term upside, but don’t want to tie up all the capital up front. A well-structured JV can align incentives, share risk, and help a system expand access while keeping clinical priorities funded.
- Use cases: new MOBs, ambulatory campuses, ASCs, imaging, and multi-site clinic rollouts.
- Benefits: shared investment + governance, capital preservation, and a clearer “why” for boards.
- Watch-outs: governance clarity, exit options, and ensuring the real estate supports—not drives—the care model.
3) Sale-Leasebacks and Real Estate Monetization (With Guardrails)
Monetization can unlock capital quickly—but it can also introduce long-term occupancy cost, control, and flexibility risks. In 2026, we’re seeing more nuanced discussions: monetizing non-core assets, carving out specific buildings, or structuring transactions that protect strategic sites.
- Good fit when: you need immediate liquidity, have stable occupancy, and can tolerate lease obligations.
- Risk factors to evaluate: long-term rent escalations, renewal options, maintenance/CapEx responsibilities, and operational constraints.
- A smarter middle ground: partial monetizations or structures that preserve a future path back to ownership.
4) “Reverse Monetizations” (Buying Back Key Outpatient Real Estate)
A notable trend heading into 2026 is the rise of health systems buying back MOBs they previously sold. This reflects a broader strategic shift: outpatient real estate is no longer just a financial asset—it’s a competitive access platform.
- Why it’s happening: systems want long-term control, physician alignment, and protection against competitor encroachment.
- When to be cautious: buying back assets can drain capital and shift maintenance responsibilities back onto the system.
- A Boldt alternative: structures that deliver control now, preserve capital today, and keep a predetermined path to ownership tomorrow.
5) Bank Debt, Private Placements, and Direct Lending
Traditional bank financing remains viable in 2026—especially for strong credits, well-leased assets, or projects with clear repayment sources. Some systems are also exploring private placements or direct lending to match project timing and reduce issuance complexity.
- Best for: straightforward projects with strong credit metrics and clear collateral.
- Trade-offs: covenants, tighter underwriting, and less flexibility if strategy shifts midstream.
- Tip: pair debt with delivery discipline—scope clarity and standardized design often matter more than the last 25 bps.
6) Tax-Exempt and Taxable Bond Options Beyond PFA
Even if PFA isn’t the issuing partner, tax-exempt financing can still be a core tool—especially for larger systems with repeat issuance needs. The key is matching the issuer, structure, and timeline to the project pipeline.
- Tax-exempt bonds can support lower borrowing costs for qualified nonprofit borrowers and projects.
- Taxable bonds or hybrid structures may make sense for certain use cases, depending on eligibility and strategic goals.
- In 2026, the winners are pairing capital markets strategy with site control and delivery speed—not treating financing as a standalone decision.
A Boldt Real Estate Lens: The Question We Start With
Instead of asking “How do we finance this building?”, we recommend starting with three operational questions:
- What access problem are we solving (and what volume, physician alignment, or service line growth does it unlock)?
- How fast do we need to open—and what is the repeatable prototype that gets us there?
- What capital structure preserves flexibility if reimbursement, leadership, or strategy shifts?
When those are clear, the right capital stack often becomes obvious—and it usually blends multiple tools: developer capital, JV equity, and selective use of tax-exempt or bank debt.
FAQs
What is PFA financing for healthcare projects? PFA is a conduit issuer that can help eligible organizations access tax-exempt (and taxable) bond financing. For qualified 501(c)(3) nonprofit borrowers, tax-exempt financing may reduce borrowing costs versus conventional debt, depending on structure and market conditions.
Why might a health system look beyond PFA financing in 2026? Because speed, flexibility, and debt capacity matter. Conduit bond financing can be effective, but some projects need faster execution or a structure that shares risk, preserves capital, or maintains an ownership pathway.
What is the most common alternative to PFA financing for outpatient growth? Programmatic delivery paired with flexible capital—often via developer capital and/or a joint venture—so the system can expand access without overloading the balance sheet.
How does Boldt Real Estate help health systems unlock capital? Boldt combines development expertise with flexible financing structures. We help systems expand outpatient access, standardize delivery, preserve debt capacity, and maintain a clear, predetermined path to ownership when desired.
Ready to Explore Your Options?
If you’re weighing PFA financing versus other capital strategies, we can help you pressure-test the options with a simple decision framework: timeline, control, cost of capital, risk sharing, and long-term flexibility. The goal isn’t to “win” a financing debate—it’s to open the right projects faster, protect resilience, and build a portfolio that supports your care model for the next decade.
Talk with Boldt: Share your project pipeline (sites, timing, and priorities). We’ll propose a capital + delivery approach that matches your strategy and governance.
